Generation of Directly Reprogrammed Human Endothelial Cells.

Area of Science:

• Cardiovascular Biology
• Cellular Reprogramming
• Regenerative Medicine

Background:

• Direct reprogramming offers a novel strategy for generating functional endothelial cells (ECs) without intermediate stem or progenitor states.
• ETV2 is a critical transcription factor identified for its role in specifying endothelial lineage.
• Precise ETV2 induction and specific combinations of growth factors/small molecules are crucial for effective endothelial reprogramming.

Purpose of the Study:

• To provide a straightforward protocol for generating two distinct types of reprogrammed ECs (rECs) from human dermal fibroblasts (HDFs).
• To characterize the properties of early and late rECs, including their neovascularization capacity and phenotypic maturity.

Main Methods:

• Direct reprogramming of human dermal fibroblasts (HDFs) using ETV2.
• Utilizing a specific combination of growth factors and small molecules to maintain the reprogrammed cellular phenotype.
• Characterization of early and late rECs for phenotype and function.

Main Results:

• Successful generation of two distinct types of rECs from HDFs.
• Early rECs exhibit robust neovascularization but lack mature EC phenotype.
• Late rECs show phenotypical similarity to human postnatal ECs with comparable neovascularization capacity to early rECs.

Conclusions:

• Direct reprogramming offers a viable method for generating functional ECs from somatic cells.
• The generated rECs are suitable for personalized disease investigations, drug discovery, and therapeutic applications.
• This protocol provides a valuable resource for advancing cardiovascular research and treatment strategies.